Table 2.
Cells | V0 | V1 | V2 | V3 |
---|---|---|---|---|
HTM 631 No Dex | 2.7* | 2.1* | 1.3* | 1.3 |
HTM 631 Dex | 1.2* | 1.3 | 1.0 | 2.0* |
HTM 682 No Dex | 5.6* | 3.0* | 4.3* | 4.0* |
HTM 682 Dex | 3.9* | 1.8* | 2.5* | 1.3 |
HTM 701 No Dex | 1.4* | 1.4* | 1.0 | 3.0* |
HTM 701 Dex | 0.6* | 0.6* | 1.5 | 1.0 |
Changes (n-fold) in the versican mRNA isoform levels (±SD) when HTM 631, 682, and 701 were grown on 400-nm pitch topography compared with planar surfaces for each condition. These comparisons were determined by dividing the change on the 400-nm pitch surface by the planar value. There were increases in the V0 and V1 isoforms with the control cells without dexamethasone (Dex), but values for the cells grown with 10−7 M dexamethasone were more variable.
Statistically significant difference between the 400-nm pitch surface and planar surface mRNA (Student’s t-test P < 0.05).